DAFNA CAPITAL MANAGEMENT LLC – PhaseBio Pharmaceuticals, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$57,000
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
-70.66%
quarter
PhaseBio Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -14.99% | -56.75K shares | -170K | $0.18 | 321.85K |
| Q2 2022 | share | 0.00% | 0 shares | -273K | $0.6 | 378.61K | |
| Q1 2022 | share | 0.00% | 0 shares | -488K | $1.32 | 378.61K | |
| Q4 2021 | share | Decrease | -37.22% | -224.43K shares | -887K | $2.62 | 378.61K |
| Q3 2021 | share | 0.00% | 0 shares | -368K | $3.11 | 603.04K | |
| Q2 2021 | share | 0.00% | 0 shares | 156K | $3.72 | 603.04K | |
| Q1 2021 | share | Increase | +88.13% | 282.5K shares | 1.01M | $3.46 | 603.04K |
| Q4 2020 | share | 0.00% | 0 shares | -48K | $3.36 | 320.54K | |
| Q3 2020 | share | 0.00% | 0 shares | -349K | $3.51 | 320.54K | |
| Q2 2020 | share | 0.00% | 0 shares | 413K | $4.6 | 320.54K | |
| Q1 2020 | share | Decrease | -11.09% | -40K shares | -1.14M | $3.31 | 320.54K |
| Q4 2019 | share | 0.00% | 0 shares | 700K | $6.11 | 360.54K | |
| Q3 2019 | share | Increase | +80.26% | 160.52K shares | -1.12M | $4.17 | 360.54K |
| Q2 2019 | share | Increase | +175.88% | 127.51K shares | 1.93M | $13.12 | 200.01K |
| Q1 2019 | share | Decrease | -27.50% | -27.5K shares | 380K | $9.51 | 72.5K |
| Q4 2018 | share | Increase | 0.00% | 100K shares | 309K | $3.09 | 100K |